Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Inflammation to Treat Cardiovascular Aging in Humans (TIVA Study)

NCT01775865 is registered in ClinicalTrials.gov with Gary L. Pierce as lead sponsor.

NCT NCT01775865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01775865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Inflammation to Treat Cardiovascular Aging in Humans (TIVA Study)
Lead sponsor
Gary L. Pierce
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
February 29, 2016
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction, endothelial dysfunction, vascular stiffness